We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Supreme Court Ruling Broadens BRCA Testing Options.
- Authors
Azvolinsky, Anna
- Abstract
The article reports on the ruling by the U.S. Supreme Court on June 13, 2013 which lifted a monopoly on BRCA genetic testing for breast cancer and invalidated the patents of molecular diagnostics company Myriad Genetics. According to the high court, isolated genes are natural phenomena that companies may not patent. Sandra Park, an attorney with the American Civil Liberties Union, who was involved in the case, also claimed that the ruling overturns the patent office's policy.
- Subjects
UNITED States; PATENT law; CANCER genetics; BRCA genes; CANCER genes; MYRIAD Genetics Inc.; DIAGNOSIS; ACTIONS &; defenses (Law)
- Publication
JNCI: Journal of the National Cancer Institute, 2013, Vol 105, Issue 22, p1671
- ISSN
0027-8874
- Publication type
Article
- DOI
10.1093/jnci/djt342